As interest in device-based hypertension therapies continues to grow, the U.S. FDA has given Valencia Technologies Corp. the go-ahead, as soon as certain conditions are met, to start an investigational device exemption (IDE) pivotal study of its nickel-sized neurostimulator for drug-resistant hypertension. The device is designed to use low-duty cycle current to stimulate the median nerve once a week for 30 minutes – without any leads. Read More
